BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8986274)

  • 21. Behavioral risk factors among women presenting for genetic testing.
    Emmons KM; Kalkbrenner KJ; Klar N; Light T; Schneider KA; Garber JE
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):89-94. PubMed ID: 10667468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fertility intentions following testing for a BRCA1 gene mutation.
    Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
    Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
    Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
    Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
    Ardern-Jones A; Kenen R; Eeles R
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pros and cons of genetic testing for breast and ovarian cancer risk.
    Frank TS; Braverman AM
    Int J Fertil Womens Med; 1999; 44(3):139-45. PubMed ID: 10435912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2.
    Goldfrank D; Chuai S; Bernstein JL; Ramon Y Cajal T; Lee JB; Alonso MC; Diez O; Baiget M; Kauff ND; Offit K; Robson M
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2311-3. PubMed ID: 17119064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
    Dorval M; Gauthier G; Maunsell E; Dugas MJ; Rouleau I; Chiquette J; Plante M; Laframboise R; Gaudet M; Bridge PJ; Simard J
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2862-7. PubMed ID: 16365001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness of heightened breast cancer risk among first-degree relatives of recently diagnosed breast cancer patients. The High Risk Breast Cancer Consortium.
    Audrain J; Lerman C; Rimer B; Cella D; Steffens R; Gomez-Caminero A
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):561-5. PubMed ID: 7549815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates.
    Croyle RT; Lerman C
    Prev Med; 1993 Mar; 22(2):284-92. PubMed ID: 8483865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interest in learning of personal genetic risk for cancer: a general population survey.
    Andrykowski MA; Munn RK; Studts JL
    Prev Med; 1996; 25(5):527-36. PubMed ID: 8888320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer.
    Peters N; Domchek SM; Rose A; Polis R; Stopfer J; Armstrong K
    Genet Test; 2005; 9(1):48-53. PubMed ID: 15857187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does a family history of male breast cancer influence risk perception and use of genetic testing?
    Schiffman SC; Chagpar AB
    Am Surg; 2010 Aug; 76(8):879-82. PubMed ID: 20726421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Awareness and attitudes concerning BRCA gene testing.
    Mogilner A; Otten M; Cunningham JD; Brower ST
    Ann Surg Oncol; 1998; 5(7):607-12. PubMed ID: 9831109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of information order on intentions to undergo predictive genetic testing: an experimental study.
    Morrison V; Henderson BJ; Taylor C; A'Ch Dafydd N; Unwin A
    J Health Psychol; 2010 Oct; 15(7):1082-92. PubMed ID: 20472604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes about genetic testing for breast-ovarian cancer susceptibility.
    Lerman C; Daly M; Masny A; Balshem A
    J Clin Oncol; 1994 Apr; 12(4):843-50. PubMed ID: 8151327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population.
    Bruno M; Tommasi S; Stea B; Quaranta M; Schittulli F; Mastropasqua A; Distante A; Di Paola L; Paradiso A
    Ann Oncol; 2004; 15 Suppl 1():I48-I54. PubMed ID: 15280188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Willingness to pay for genetic testing: a study of attitudes in a Canadian population.
    Ries NM; Hyde-Lay R; Caulfield T
    Public Health Genomics; 2010; 13(5):292-300. PubMed ID: 19864872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.
    Sanderson SC; Wardle J; Jarvis MJ; Humphries SE
    Prev Med; 2004 Sep; 39(3):458-64. PubMed ID: 15313084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interest in breast cancer genetic testing among Icelandic women.].
    Arnadóttir G; Sigurðardóttir V; Jónsson FH; Valdimarsdóttir HB
    Laeknabladid; 2000 Nov; 86(11):771-7. PubMed ID: 17018964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.